Search results
Results from the WOW.Com Content Network
In 2022, more than 1.3 million different patients from all 50 states and 138 countries were seen at Mayo Clinic facilities. Research. Mayo Clinic researchers contribute to understanding disease processes, best clinical practices, and translating findings from the laboratory to clinical practice.
The Mayo Clinic College of Medicine and Science (MCCMS), formerly known as Mayo Clinic College of Medicine (MCCM), is a private postgraduate-only research university based in Rochester, Minnesota, United States that trains physicians, scientists, and allied health professionals.
The Mayo Clinic Alix School of Medicine (MCASOM), formerly known as Mayo Medical School (MMS), is a research-oriented medical school based in Rochester, Minnesota, with additional campuses in Arizona and Florida.
Mayo Clinic Graduate School of Biomedical Sciences is a national center of excellence for the biomedical research training of students from backgrounds underrepresented in science. This training is supported by three long-running NIH diversity training grants.
Research and education. Mayo Clinic Health System has research partnerships with University of Wisconsin's UW-La Crosse and UW-Eau Claire campuses. The groups have collaborated on cancer research, and in 2020 worked together developing COVID-19 tests.
Mayo's research is focused on cancer, neurological and neuro-degenerative diseases. The goal of this research is to bring the advances from laboratory research to patient care as quickly as possible. [1]
The Mayo Clinic Cancer Center (MCCC) is a National Cancer Institute (NCI)-designated Cancer Center and a division of the Mayo Clinic. The MCCC has 3 locations in the United States: Phoenix, Arizona, Jacksonville, Florida, and Rochester, Minnesota.
The Mayo Clinic Center for Innovation (CFI), embedded within Mayo Clinic, is one of the United States's first and largest health care delivery innovation group working within a major academic medical center.
International Clinical Research Center Brno (ICRC) is a conceptually novel project in biomedical research and clinical patient care which is being developed by the Czech Republic and the Mayo Clinic in Rochester, Minnesota.
While she was working at the Mayo Clinic, Perez was essential to the N9831 trial, which demonstrated the impact of adding trastuzumab (Herceptin®) to improve disease-free and overall survival for patients with early-stage HER-2 positive breast cancer.